About

OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen (Megan Morrone/Axios)

OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen (Megan Morrone/Axios) OpenAI launches GPT-Rosalind, an AI model for life sciences research, including drug discovery, as a research preview for customers such as Moderna and Amgen (Megan Morrone/Axios) Reviewed by swadu on April 16, 2026 Rating: 5

No comments:

Powered by Blogger.